Lithuania
Ligence, founded in 2019 and headquartered in Lithuania, is revolutionizing the echocardiography landscape with their slogan "Echocardiography workflow that makes sense." The company is at the intersection of AI, Analytics, Health Care, and Machine Learning, with a mission to make cardiac ultrasound more accessible, cost-effective, and less reliant on manual input.
Cardiac ultrasounds, while safe and economical, typically require manual work that consumes 50-85% of the test time. Ligence addresses this inefficiency by automating the analysis process, thereby enhancing the test's accessibility and affordability. This innovation is crucial in a healthcare setting where time and precision are essential.
A testament to its potential, Ligence secured a €3.00M seed investment on 01 November 2024. The investment round was backed by notable investors including Simpact, Lemonade Stand, Coinvest Capital, NGL, and the EIC Fund, highlighting strong investor confidence in its vision and technological prowess.
